A Study of Darbepoetin Alfa in Anemic Subjects With Low Risk Myelodysplastic Syndrome
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect of 13 weeks of darbepoetin alfa treatment
on erythroid response in anemic subjects with low risk Myelodysplastic Syndrome (MDS).